🇺🇸 A message from @Megan__Romano, the first American and female athlete of the @Enhanced_Games. 🥇 World & NCAA Champion 📅 Competing May 2026 in Las Vegas 🏊‍♀️ 50m & 100m Freestyle

Of course my opinion/bias. But $ATAI Life Sciences may end up being the biggest success stories you will hear not just in biotech, but in all the stock market. It's still early...... But this will be a fun couple of years and beyond. This could arguably be a 10 Billion $ company

The enhanced movement is unstoppable! Big welcome to @Megan__Romano, the first American and first female athlete to join the @enhanced_games! Memorial Day Weekend 2026!

Amazing chart, Venezuela used to be wealthier than Poland. Poland introduced capitalism & free market principles, Venezuela followed socialism. Capitalism makes people wealthier, socialism always ends in bitter poverty and misery. Why are young people so fascinated by socialism?

Throwback to Monday's #Alphanooner with Christian Angermayer @C_Angermayer Co-Founder & Chairman of Atai Life Sciences @atai_life and special host Noah Hamman @HammanShares talking #Psychedelics #DMT #MDMA #MentalHealth #Wellness #Therapeutics

I’ve been saying for a while now that two things are inevitable: a) A wave of biotech M&A is coming, as Big Pharma scrambles to fill looming patent cliffs, and b) The psychedelic space will see the biggest frenzy - because pharma CEOs will realize, quite bluntly, that only a few companies have real commercial potential. In psychedelics, I believe pharma will look beyond the surface and focus on three things: • Short-acting compounds – there’s simply no real commercial future for 6-hour or longer treatments. • Strong, defensible IP – no patents, no deal. • Scalable, healthcare-friendly delivery – IV is limiting, and inhalation is unlikely to be pharma’s choice. Intranasal, oral, or transmucosal is ideal. That narrows the field… a lot. I’m very proud that, through the tough years for biotech, our team at $ATAI kept building and focused relentlessly on exactly these three USPs. @atai_life now has by far the most comprehensive portfolio of short-acting psychedelics, a vast patent estate, and patient-friendly (and patented!) delivery methods. And then there is our discovery pipeline. Let’s go! 🚀

The EU is about to die. The US-EU trade deal is just the latest proof of Europe’s decline. Let’s be clear: this deal isn’t a scandal. It’s not even surprising. It’s just the brutal reality of where we stand in the world today. No leverage. No unity. No relevance. A mirror held to our face. And what we see is painful, especially for those of us who believe in the idea of Europe. Because I do believe in Europe. In a strong, competitive and united Europe. It’s a plea to fix what’s broken before it’s too late. But the current non-federal EU setup is neither fish nor fowl. It has become the problem. Let’s look at the hard numbers: - In 2008, the EU and the US had around 16 trillion USD in GDP. - Today: the US is at approximately 28 trillion, the EU at 18 trillion. - That’s plus 75 percent versus just 12 percent. - Germany is stuck in recession - In 2005, 4 of the world’s 10 largest companies were European. - In 2024: zero. Why? Because Europe is fundamentally broken. 27 members, zero alignment. No capital union. No unified tech or energy strategy. Regulatory arbitrage everywhere, even inside the system. We’re weakening ourselves from within. We don’t act like a union. We act like 27 separate middle powers stuck in endless negotiation. While we’re still debating whether we should act, others have already built and delivered. The EU has become a bureaucratic tumor that keeps growing uncontrollably. More layers, more delays, more vetoes. Less output, less speed, less relevance. So where do we go from here? - We need urgent, bold reforms. - A real capital markets union. - Clear strategic priorities. - Dramatic deregulation and debureaucratization - And the political will to act as one. Without that, I predict more Brexits in the next 10 years. And with them, the collapse of the EU as we know it. And it starts with the foundation for everything: capital. We need one unified European capital market. One stock exchange with deep liquidity, not 20 fragmented ones with empty order books. A true single market for investments, equity, IPOs and venture funding. Without that, we won’t finance innovation. And without funding and supporting innovation, Europe will remain irrelevant, and will have to accept whatever "deal" we’re given.

One more - perhaps more mundane - thing that Bitcoin and psychedelics, and here especially $ATAI, have in common: @atai_life today is like Bitcoin under $20K. All the stars are aligning: – Unprecedented patient demand – Compelling clinical data – A shifting regulatory landscape As I’ve always said about Bitcoin: it just makes sense. Same for atai: it just makes sense. Two years from now, people will look back and wonder: "How on earth did I miss that?"

Beyond the financial rationale for adding Bitcoin to $ATAI treasury strategy, there’s a deeper philosophical connection: many Bitcoiners also believe in psychedelics, because ultimately, both are about one thing - freedom.

Every billion dollar founder I know dropped off the face of the earth for years. We built the perfect home for these people. It’s called HF0. In our last batch, teams raising after demo day hit an avg valuation of $82M. Applications for F25 open today.